To this end, over-expression of inflammatory cytokines in the brain of AD mouse models also resulted in alleviation of AD pathology [18], including our own where sustained expression of interleukin-1β (IL-1β) in mouse hippocampus promoted plaque clearance in the APP/PS1 double transgenic mouse model [19]. This evidence concerns the gene APP and Alzheimer disease.